Attribute Selection for a Discrete Choice Experiment Incorporating a Best-Worst Scaling Survey.


Journal

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
ISSN: 1524-4733
Titre abrégé: Value Health
Pays: United States
ID NLM: 100883818

Informations de publication

Date de publication:
04 2021
Historique:
received: 09 04 2020
revised: 23 09 2020
accepted: 30 10 2020
entrez: 12 4 2021
pubmed: 13 4 2021
medline: 23 9 2021
Statut: ppublish

Résumé

Although literature exists on using qualitative methods to generate potential attributes for a discrete choice experiment (DCE), there is little on selecting which attributes to include. We present a case study in which a best-worst scaling case 1 (BWS-1) survey was used to guide attribute selection for a DCE. The case study's context was the decision making of professionals around the choice of augmentative and alternative communication (AAC) systems for children with limited natural speech. BWS-1 survey attributes were generated from literature reviews and focus groups. DCE attributes were selected from BWS-1 attributes. The selection criteria were: include mostly important attributes; create coherent descriptions of children and AAC systems; address the project's research aims; have an appropriate respondent burden. Attributes' importance was judged using BWS-1 relative importance scores. The BWS-1 survey included 19 child and 18 AAC device/system attributes and was administered to N = 93 AAC professionals. Four child and five device/system attributes were selected for the DCE, administered to N = 155 AAC professionals. In this case study BWS-1 results were useful in DCE attribute selection. Four recommendations are made for future studies: define selection criteria for DCE attributes a priori; consider the impact participant's perspective will have on BWS-1 and DCE results; clearly define key terminology at the start of the study and refine it as the study progresses to reflect interim findings; BWS will be useful when there is little existing stated preference work on a topic and/or qualitative work is difficult.

Identifiants

pubmed: 33840436
pii: S1098-3015(20)34512-5
doi: 10.1016/j.jval.2020.10.025
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

575-584

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Auteurs

Edward J D Webb (EJD)

Leeds Institute of Health Sciences, University of Leeds, Leeds, England, UK; Choice Modelling Centre, University of Leeds, Leeds, England, UK. Electronic address: e.j.d.webb@leeds.ac.uk.

David Meads (D)

Leeds Institute of Health Sciences, University of Leeds, Leeds, England, UK; Choice Modelling Centre, University of Leeds, Leeds, England, UK.

Yvonne Lynch (Y)

Faculty of Health, Psychology and Social Care, Manchester Metropolitan University, Manchester, England, UK.

Simon Judge (S)

Barnsley Assistive Technology Team, Barnsley Hospital NHS Foundation Trust, Barnsley, England, UK; Institute for Transport Studies, University of Leeds, Leeds, England, UK.

Nicola Randall (N)

Barnsley Assistive Technology Team, Barnsley Hospital NHS Foundation Trust, Barnsley, England, UK.

Juliet Goldbart (J)

Barnsley Assistive Technology Team, Barnsley Hospital NHS Foundation Trust, Barnsley, England, UK.

Stuart Meredith (S)

Leeds Institute of Health Sciences, University of Leeds, Leeds, England, UK.

Liz Moulam (L)

Barnsley Assistive Technology Team, Barnsley Hospital NHS Foundation Trust, Barnsley, England, UK.

Stephane Hess (S)

Choice Modelling Centre, University of Leeds, Leeds, England, UK.

Janice Murray (J)

Barnsley Assistive Technology Team, Barnsley Hospital NHS Foundation Trust, Barnsley, England, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH